2012 Whan HaClinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment J Neurooncol.
2012 A case of isolated light chain deposition disease in the duodenum J Korean Med Sci.
2011 Primary Spinal Natural Killer/T-cell Lymphoma Successfully Treated with Concurrent Chemoradiotherapy and Autologous Stem Cell Transplantation Spine (Phila Pa 1976).
2009 Sunitinib-induced reversible posterior leukoencephalopathy syndrome after rifampin discontinuation. The Korean Journal of Medicine.
2009 Rapidly progressing neurocutaneous melanosis (NCM) in a 49-year-old woman. The Korean Journal of Medicine
2009 Two cases of thyroid small cell carcinoma. The Korean Journal of Medicine
2009 Resected colorectal liver metastases: Does the survival differ according to postoperative chemotherapy regimen? J Surg Oncol.
2009 Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer. Lung Cancer.
2009 Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res Treat.
Clinical Trials
Representative list of participating clinical trials as co-investigator during last 3 years
Phase III multicenter Randomized Open-label study of irinotecan plus CapEcitabine versus capEcitabine in patients previously treateD with anthracycline and taxane for HER2 negative metastatic breast cancer [PROCEED]
Randomized phase II study of lapatinib plus vinorelbine versus vinorelbine in patients with HER2 positive metastatic breast cancer progressed after lapatinib and trastuzumab treatment
Gemcitabine-Carboplatin versus Gemcitabine-Oxaliplatin in Cisplatin Un-fit Advanced Urothelial Carcinoma: Randomized PHase II Study (COACH Study)
A phase II study of TKI258 in patients with castration-resistant prostate cancer(CTKI258AKR03T)
A Phase III, Multicenter, Randomized Trial of Maintenance Versus Observation After Achieving Clinical Response in Patients With Metastatic or Recurrent Breast Cancer Who Received 6 Cycles of Gemcitabine Plus Paclitaxel(GP) as First-line Chemotherapy
A phase III sudy of ErbB2 positive advanced or metastatic gastric or esophageal or gastroesophageal junction adenocarcinoma treated with capecitabine plus oxaliplatin with or without lapaitnib
Analysis of clinical outcome, predictive and prognostic factors of therapeutic responses in patients who treated with Doxorubicin & docetaxel neoadjuvant chemotherapy in clinical stage II or III Breast Cancer
Randomized, open label, phase III trial of CP-751,871 in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer